SCHEMBL20058487

SCHEMBL20058487

CN1CCC2(CC1)CN(C(=O)c1ccc(F)cc1)CC1(CC1)O2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.50
MAPK1 P28482 1/20 0.46
GPR183 P32249 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
HTT P42858 2/20 0.43
POLB P06746 2/20 0.43
LMNA P02545 2/20 0.43
CYP2D6 P10635 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD11B1 P28845 1/20 0.43
NPC1 O15118 1/20 0.43
TP53 P04637 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NAMPT P43490 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20058379 0.82 KDM4E (0.45) EPHX2MAPK1SMN1; SMN2HTTMEN1
SCHEMBL19107360 0.82 MEN1 (0.48) EPHX2GPR183MEN1KMT2A
SCHEMBL9364495 0.76 EPHX2 (0.77) EPHX2SMN1; SMN2HTTPOLBLMNA
SCHEMBL17318817 0.75 L3MBTL1 (0.42) SIGMAR1
SCHEMBL20153274 0.74 LMNA (0.50) EPHX2MAPK1SMN1; SMN2HTTPOLB
SCHEMBL17868397 0.74 HSD11B1 (0.53) EPHX2GPR183SMN1; SMN2POLBMEN1
SCHEMBL18785481 0.74 TSHR (0.47) POLBLMNACYP2D6NPC1TP53
SCHEMBL20058380 0.73 L3MBTL1 (0.55) EPHX2MAPK1SMN1; SMN2CYP2D6ALDH1A1
SCHEMBL22305103 0.70 CA12 (0.71) EPHX2SMN1; SMN2POLBMEN1KMT2A
SCHEMBL6985975 0.70 CA12 (0.71) EPHX2SMN1; SMN2POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3149005-B1 AMIDE DERIVATIVES OF 1-OXA-4,9-DIAZASPIRO UNDECANE COMPOUNDS HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE LABOR DR (ES) 2018-04-18 EP disclosed